Singh Shawn 4
4 · Vistagen Therapeutics, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2024-06-28$2.96/sh+4,854$14,358→ 10,487 total
Holdings
- 20,875(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended.